May 2, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 26,274 shares of Abrdn Life Sciences Investors at $13.46 per share, a transaction worth $353.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.